Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes (GLP-1)

This study has been completed.
Sponsor:
Collaborators:
University of Nebraska
Astellas Pharma US, Inc.
Lantheus Medical Imaging
Information provided by (Responsible Party):
Sharon Mulvagh, Mayo Clinic
ClinicalTrials.gov Identifier:
NCT01021865
First received: October 30, 2009
Last updated: October 20, 2014
Last verified: October 2014